AlzChem Financial Statements From 2010 to 2025
| ALZCF Stock | USD 166.85 0.00 0.00% |
Check AlzChem Group financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among AlzChem Group's main balance sheet or income statement drivers, such as , as well as many indicators such as . AlzChem financial statements analysis is a perfect complement when working with AlzChem Group Valuation or Volatility modules.
AlzChem |
AlzChem Group AG Company Current Valuation Analysis
AlzChem Group's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current AlzChem Group Current Valuation | 276.28 M |
Most of AlzChem Group's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, AlzChem Group AG is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, AlzChem Group AG has a Current Valuation of 276.28 M. This is 97.58% lower than that of the Basic Materials sector and 99.1% lower than that of the Specialty Chemicals industry. The current valuation for all United States stocks is 98.34% higher than that of the company.
AlzChem Group AG Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining AlzChem Group's current stock value. Our valuation model uses many indicators to compare AlzChem Group value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across AlzChem Group competition to find correlations between indicators driving AlzChem Group's intrinsic value. More Info.AlzChem Group AG is rated fourth in return on equity category among its peers. It also is rated fourth in return on asset category among its peers reporting about 0.19 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for AlzChem Group AG is roughly 5.22 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the AlzChem Group's earnings, one of the primary drivers of an investment's value.About AlzChem Group Financial Statements
AlzChem Group stakeholders use historical fundamental indicators, such as AlzChem Group's revenue or net income, to determine how well the company is positioned to perform in the future. Although AlzChem Group investors may analyze each financial statement separately, they are all interrelated. For example, changes in AlzChem Group's assets and liabilities are reflected in the revenues and expenses on AlzChem Group's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in AlzChem Group AG. Please read more on our technical analysis and fundamental analysis pages.
AlzChem Group AG develops, produces, and trades chemical products in Germany, European Union, rest of Europe, Asia, NAFTA region, and internationally. AlzChem Group AG was founded in 1908 and is based in Trostberg, Germany. Alzchem Group operates under Specialty Chemicals classification in the United States and is traded on OTC Exchange. It employs 1464 people.
Currently Active Assets on Macroaxis
| DD | Dupont De Nemours | |
| CRDO | Credo Technology Group | |
| GOOG | Alphabet Inc Class C | |
| BAC | Bank of America | |
| CRM | Salesforce |
Other Information on Investing in AlzChem Pink Sheet
AlzChem Group financial ratios help investors to determine whether AlzChem Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in AlzChem with respect to the benefits of owning AlzChem Group security.